Weight Loss Drugs-North America Market Status and Trend Report 2013-2023
SKU ID :MI-10908469 | Published Date: 28-Jan-2018 | No. of pages: 147Description
TOC
Table of Contents
Chapter 1 Overview of Weight Loss Drugs
1.1 Definition of Weight Loss Drugs in This Report
1.2 Commercial Types of Weight Loss Drugs
1.2.1 Liauid
1.2.2 Tablets
1.3 Downstream Application of Weight Loss Drugs
1.3.1 Weight-reducing Aid
1.3.2 Other
1.4 Development History of Weight Loss Drugs
1.5 Market Status and Trend of Weight Loss Drugs 2013-2023
1.5.1 North America Weight Loss Drugs Market Status and Trend 2013-2023
1.5.2 Regional Weight Loss Drugs Market Status and Trend 2013-2023
Chapter 2 North America Market Status and Forecast by Regions
2.1 Market Status of Weight Loss Drugs in North America 2013-2017
2.2 Consumption Market of Weight Loss Drugs in North America by Regions
2.2.1 Consumption Volume of Weight Loss Drugs in North America by Regions
2.2.2 Revenue of Weight Loss Drugs in North America by Regions
2.3 Market Analysis of Weight Loss Drugs in North America by Regions
2.3.1 Market Analysis of Weight Loss Drugs in United States 2013-2017
2.3.2 Market Analysis of Weight Loss Drugs in Canada 2013-2017
2.3.3 Market Analysis of Weight Loss Drugs in Mexico 2013-2017
2.4 Market Development Forecast of Weight Loss Drugs in North America 2018-2023
2.4.1 Market Development Forecast of Weight Loss Drugs in North America 2018-2023
2.4.2 Market Development Forecast of Weight Loss Drugs by Regions 2018-2023
Chapter 3 North America Market Status and Forecast by Types
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Weight Loss Drugs in North America by Types
3.1.2 Revenue of Weight Loss Drugs in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Weight Loss Drugs in North America by Types
Chapter 4 North America Market Status and Forecast by Downstream Industry
4.1 Demand Volume of Weight Loss Drugs in North America by Downstream Industry
4.2 Demand Volume of Weight Loss Drugs by Downstream Industry in Major Countries
4.2.1 Demand Volume of Weight Loss Drugs by Downstream Industry in United States
4.2.2 Demand Volume of Weight Loss Drugs by Downstream Industry in Canada
4.2.3 Demand Volume of Weight Loss Drugs by Downstream Industry in Mexico
4.3 Market Forecast of Weight Loss Drugs in North America by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Weight Loss Drugs
5.1 North America Economy Situation and Trend Overview
5.2 Weight Loss Drugs Downstream Industry Situation and Trend Overview
Chapter 6 Weight Loss Drugs Market Competition Status by Major Players in North America
6.1 Sales Volume of Weight Loss Drugs in North America by Major Players
6.2 Revenue of Weight Loss Drugs in North America by Major Players
6.3 Basic Information of Weight Loss Drugs by Major Players
6.3.1 Headquarters Location and Established Time of Weight Loss Drugs Major Players
6.3.2 Employees and Revenue Level of Weight Loss Drugs Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
Chapter 7 Weight Loss Drugs Major Manufacturers Introduction and Market Data
7.1 Roche
7.1.1 Company profile
7.1.2 Representative Weight Loss Drugs Product
7.1.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Roche
7.2 GSK group
7.2.1 Company profile
7.2.2 Representative Weight Loss Drugs Product
7.2.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of GSK group
7.3 Teva
7.3.1 Company profile
7.3.2 Representative Weight Loss Drugs Product
7.3.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Teva
7.4 Sandoz(Novartis)
7.4.1 Company profile
7.4.2 Representative Weight Loss Drugs Product
7.4.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Sandoz(Novartis)
7.5 STADA-VN J.V.Co., Ltd
7.5.1 Company profile
7.5.2 Representative Weight Loss Drugs Product
7.5.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of STADA-VN J.V.Co., Ltd
7.6 Hexal AG
7.6.1 Company profile
7.6.2 Representative Weight Loss Drugs Product
7.6.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Hexal AG
7.7 National Company For Pharmaceutical Industry
7.7.1 Company profile
7.7.2 Representative Weight Loss Drugs Product
7.7.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of National Company For Pharmaceutical Industry
7.8 Lunan Pharmaceutical Group Corporation
7.8.1 Company profile
7.8.2 Representative Weight Loss Drugs Product
7.8.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Lunan Pharmaceutical Group Corporation
7.9 Zein Pharmaceutical
7.9.1 Company profile
7.9.2 Representative Weight Loss Drugs Product
7.9.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Zein Pharmaceutical
7.10 Hisun
7.10.1 Company profile
7.10.2 Representative Weight Loss Drugs Product
7.10.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Hisun
7.11 Taj Pharmaceuticals Ltd
7.11.1 Company profile
7.11.2 Representative Weight Loss Drugs Product
7.11.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Taj Pharmaceuticals Ltd
7.12 Kabir Life Sciences & Research
7.12.1 Company profile
7.12.2 Representative Weight Loss Drugs Product
7.12.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Kabir Life Sciences & Research
7.13 Dm Pharma
7.13.1 Company profile
7.13.2 Representative Weight Loss Drugs Product
7.13.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Dm Pharma
7.14 China Zhongshan Pharm
7.14.1 Company profile
7.14.2 Representative Weight Loss Drugs Product
7.14.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of China Zhongshan Pharm
Chapter 8 Upstream and Downstream Market Analysis of Weight Loss Drugs
8.1 Industry Chain of Weight Loss Drugs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Weight Loss Drugs
9.1 Cost Structure Analysis of Weight Loss Drugs
9.2 Raw Materials Cost Analysis of Weight Loss Drugs
9.3 Labor Cost Analysis of Weight Loss Drugs
9.4 Manufacturing Expenses Analysis of Weight Loss Drugs
Chapter 10 Marketing Status Analysis of Weight Loss Drugs
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
Tables & Figures
List of Tables
Table Advantage and Disadvantage of Liauid
Table Advantage and Disadvantage of Tablets
Table Consumption Volume of Weight Loss Drugs in North America by Regions 2013-2017
Table Revenue of Weight Loss Drugs in North America by Regions 2013-2017
Table Consumption Volume of Weight Loss Drugs in North America by Regions 2018-2023
Table Revenue of Weight Loss Drugs in North America by Regions 2018-2023
Table Consumption Volume of Weight Loss Drugs in North America by Types 2013-2017
Table Revenue of Weight Loss Drugs in North America by Types 2013-2017
Table Consumption Volume of Weight Loss Drugs by Types in United States 2013-2017
Table Consumption Volume of Weight Loss Drugs by Types in Canada 2013-2017
Table Consumption Volume of Weight Loss Drugs by Types in Mexico 2013-2017
Table Consumption Volume Forecast of Weight Loss Drugs in North America by Types 2018-2023
Table Revenue Forecast of Weight Loss Drugs in North America by Types 2018-2023
Table Demand Volume of Weight Loss Drugs in North America by Downstream Industry 2013-2017
Table Demand Volume of Weight Loss Drugs by Downstream Industry in United States 2013-2017
Table Demand Volume of Weight Loss Drugs by Downstream Industry in Canada 2013-2017
Table Demand Volume of Weight Loss Drugs by Downstream Industry in Mexico 2013-2017
Table Demand Volume Forecast of Weight Loss Drugs in North America by Downstream Industry 2018-2023
Table Sales Volume of Weight Loss Drugs in North America by Major Players 2013-2017
Table Revenue of Weight Loss Drugs in North America by Major Players 2013-2017
Table Headquarters Location and Established Time of Weight Loss Drugs Major Players
Table Employees and Revenue Level of Weight Loss Drugs Major Players
Table Representative Weight Loss Drugs Product One of Roche
Table Representative Weight Loss Drugs Product Two of Roche
Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Roche 2013-2017
Table Representative Weight Loss Drugs Product One of GSK group
Table Representative Weight Loss Drugs Product Two of GSK group
Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of GSK group 2013-2017
Table Representative Weight Loss Drugs Product One of Teva
Table Representative Weight Loss Drugs Product Two of Teva
Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Teva 2013-2017
Table Representative Weight Loss Drugs Product One of Sandoz(Novartis)
Table Representative Weight Loss Drugs Product Two of Sandoz(Novartis)
Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Sandoz(Novartis) 2013-2017
Table Representative Weight Loss Drugs Product One of STADA-VN J.V.Co., Ltd
Table Representative Weight Loss Drugs Product Two of STADA-VN J.V.Co., Ltd
Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of STADA-VN J.V.Co., Ltd 2013-2017
Table Representative Weight Loss Drugs Product One of Hexal AG
Table Representative Weight Loss Drugs Product Two of Hexal AG
Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Hexal AG 2013-2017
Table Representative Weight Loss Drugs Product One of National Company For Pharmaceutical Industry
Table Representative Weight Loss Drugs Product Two of National Company For Pharmaceutical Industry
Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of National Company For Pharmaceutical Industry 2013-2017
Table Representative Weight Loss Drugs Product One of Lunan Pharmaceutical Group Corporation
Table Representative Weight Loss Drugs Product Two of Lunan Pharmaceutical Group Corporation
Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Lunan Pharmaceutical Group Corporation 2013-2017
Table Representative Weight Loss Drugs Product One of Zein Pharmaceutical
Table Representative Weight Loss Drugs Product Two of Zein Pharmaceutical
Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Zein Pharmaceutical 2013-2017
Table Representative Weight Loss Drugs Product One of Hisun
Table Representative Weight Loss Drugs Product Two of Hisun
Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Hisun 2013-2017
Table Representative Weight Loss Drugs Product One of Taj Pharmaceuticals Ltd
Table Representative Weight Loss Drugs Product Two of Taj Pharmaceuticals Ltd
Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Taj Pharmaceuticals Ltd 2013-2017
Table Representative Weight Loss Drugs Product One of Kabir Life Sciences & Research
Table Representative Weight Loss Drugs Product Two of Kabir Life Sciences & Research
Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Kabir Life Sciences & Research 2013-2017
Table Representative Weight Loss Drugs Product One of Dm Pharma
Table Representative Weight Loss Drugs Product Two of Dm Pharma
Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Dm Pharma 2013-2017
Table Representative Weight Loss Drugs Product One of China Zhongshan Pharm
Table Representative Weight Loss Drugs Product Two of China Zhongshan Pharm
Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of China Zhongshan Pharm 2013-2017
Companies
- PRICE
-
$3480$5980